One of the qualitative differences between the HCC and benign liver responses to immune cells is the genes of the acute response phase pathway: Genes such as SOD2 or ORM1 were upregulated in HCC but downregulated in benign liver. The gene discussed is ORM1; the disease is hepatocellular carcinoma.